The SSI Mantra 3 has been put in in 75 hospitals around the globe to this point. | Supply: SS Improvements Worldwide
SS Improvements Worldwide Inc. immediately introduced that it has accomplished its first robotic cardiac surgical procedure within the Americas with its SSi Mantra 3 surgical robotic system.
On June 8, Dr. Juan Zuniga, a cardiothoracic surgeon at Interhospital in Guayaquil, Ecuador, grew to become the primary surgeon to carry out a robotic cardiac surgical procedure within the Americas and Western Hemisphere utilizing the SSi Mantra 3. The surgical procedure concerned a robotic Atrial Septal Defect closure. This process repairs a gap between the higher two chambers of the center.
“On the heels of SSi Mantra’s debut in Latin American robotic surgical procedures, we determined to leverage this superior system in complicated specialties, significantly in cardiovascular surgical procedures,” Dr. Zuniga stated.
“The expertise was good, this tools was very simple to deal with and manipulate, and the outcomes had been efficient as we did a transesophageal echocardiogram to confirm the entire closure of the communication between the 2 higher chambers of the center,” he stated. “We had been very proud of the leads to attaining a profitable closure, and the affected person is recovering very nicely.”
SSi Mantra aids minimally invasive procedures
Interhospital is the primary hospital in South America to put in the SSi Mantra. It has carried out quite a lot of complicated surgical procedures with the surgical robotic system since its set up.
“As a result of it’s a minimally invasive process, the restoration is far quicker, bleeding a lot much less, and since it’s completed robotically, the manipulation of the tissues is rather more exact, and so is the suturing,” added Dr. Zuniga. “It offers the surgeon the boldness that each sew that’s made with the platform is positioned exactly and with out complication.”
SS Improvements described the SSi Mantra as “a user-friendly, modular, multi-arm system.” Its know-how options embody:
- Three to 5 modular robotic arms
- An open-faced ergonomic surgeon command heart
- A big 3D 4K monitor
- A contact panel monitor for all patient-related info shows
- A digital real-time picture of the robotic patient-side arm carts
- The power to superimpose 3D fashions for diagnostic imaging
A imaginative and prescient cart gives the table-side workforce with the identical magnified 3D 4K view because the surgeon to offer higher security and effectivity. The SSi Mantra makes use of greater than 40 forms of robotic endo-surgical devices to assist completely different specialties, together with cardiac surgical procedure. The system has additionally been clinically validated in India, stated SS Improvements.
Now accepting session submissions!
SS Improvements surpasses 4,000 robotic surgical procedures
Final month, SS Improvements introduced that SSi Mantra has been utilized in 4,000 surgical procedures. These operations spanned greater than 100 several types of surgical procedures with none problems, accidents, or mortalities.
The Fort Lauderdale, Fla.-based firm famous this included roughly 215 cardiac surgical procedures. Six of those had been efficiently carried out by way of telesurgery throughout India with the SSi Mantra 3 surgical robotic system.
The Robotic Report beforehand mentioned SS Improvements’ telesurgery technique with Dr. Vishwa Srivastava, chief working officer and chairman of the board.
SS Improvements stated it has developed methods to make robotic surgical procedure reasonably priced and accessible to a bigger phase of the worldwide inhabitants. The corporate’s product vary contains its proprietary SSi Mantra and its complete suite of SSi Mudra devices, which assist quite a lot of surgical procedures.
The corporate launched its newest system, the SSi Mantra 3, in July 2024. The system acquired regulatory approval for distant surgical procedure and teleproctoring from the Central Medicine Commonplace Management Group (CDSCO). This opens the door for distant surgical procedures and medical schooling.
In Could 2025, SS Improvements revealed plans to submit a de novo classification request to the U.S. Meals and Drug Administration for the system.
